COVID-19: Epidemiology and pathophysiology: Difference between revisions
(Epi+Path - COVID-19) |
No edit summary |
||
| Line 6: | Line 6: | ||
== Geographic Distribution == | == Geographic Distribution == | ||
==Pathophysiology== | |||
*[[Acute respiratory distress syndrome|ARDS]] - Possibly due to direct alveolar damage by the virus AND inflammatory reaction. <ref>Xu Z, Shi L, Wang Y et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. 2020;8(4):420-422. doi:10.1016/s2213-2600(20)30076-x</ref> | |||
*[[Cytokine release syndrome|Cytokine Storm]] | |||
Revision as of 17:18, 6 April 2020
Virology
Origins
Geographic Distribution
Pathophysiology
- ARDS - Possibly due to direct alveolar damage by the virus AND inflammatory reaction. [1]
- Cytokine Storm
Risk Factors
Transmission
Incubation Period
Infectious Period
- ↑ Xu Z, Shi L, Wang Y et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. 2020;8(4):420-422. doi:10.1016/s2213-2600(20)30076-x